Skip to content
Governance Register

← US public companies

Panacea Life Sciences Holdings, INC.

SEC CIK 1552189 · PLSH · last insider filing 2023-09-20

Directors (from insider filings)

NameCapacity as filedFilings
Buttorff Leslie Director · Chief Executive Officer filed 2021 - 2023
Wert Lawrence Director filed 2021 - 2022
Nerger Janice Director filed 2021 - 2021
Alberttis Alvaro Daniel Director · CHIEF OPERATING OFFICER filed 2020 - 2021
Puzder Ken Director · CHIEF FINANCIAL OFFICER filed 2019 - 2020
Ceed2Med LLC Director filed 2019 - 2019
Yampolsky Vladislav Director filed 2019 - 2019
Thompson Jeffrey M Director filed 2019 - 2019
Esval Kevin James Director filed 2019 - 2019
Price John C Director filed 2019 - 2019
Schwartz Steven A Director filed 2019 - 2019
Gilbert Jonathan Director · Executive Chairman filed 2019 - 2019
Ryan Timothy John Director · Executive Vice President filed 2017 - 2018
Young Philip J Director · President and CEO filed 2017 - 2018
Dimitrov Krassen Director filed 2017 - 2017

Officers (from insider filings)

NameTitle as filedFilings
Berman Nathan Joel CONTROLLER & PRIN ACTNG OFCR filed 2021 - 2021
Johnson Andrew L. Chief Strategy Officer filed 2019 - 2021
Du Chesne Derek Chief Growth Officer filed 2020 - 2020
Aloi Emiliano Angel President filed 2019 - 2019
Wendt Kelley A CHIEF FIN OFFICER AND TREAS filed 2017 - 2018
Erickson James R. Chief Business Officer filed 2017 - 2018

About this record

From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.

Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.